Peru authorizes use of Johnson & Johnson COVID-19 vaccine

Photo: EFE

Photo: EFE

09:38 | Lima, Jul. 9.

The Ministry of Health (Minsa) authorized the Conditional Sanitary Registry of the Janssen COVID-19 Vaccine, known internationally as the Johnson & Johnson vaccine.

The compound registered by pharmaceutical companies of the Johnson & Johnson group (the United States) and Janssen (Belgium) was thus authorized to be imported to Peru and used in the country.

"One of the most remarkable characteristics of the Johnson & Johnson vaccine is that it is a single dose jab," 
Minsa highlighted in a communiqué
 on Thursday.

For a year

The Conditional Sanitary Registry by the General Directorate for Medicines, Input, and Drugs (Digemid) will last one year and can be renewed.

"This type of health registry was created to allow experimental vaccines against the coronavirus SARS-CoV-2 to be used and imported to Peru," the health sector added.

Johnson & Johnson's compound is the fourth vaccine against COVID-19 authorized for use in Peru —after Sinopharm, Pfizer, and AstraZeneca.


Published: 7/9/2021